Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Watson

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Selective S1P1 Receptor Agonist Efficacious at Low Oral Dose and Devoid of Effects on Heart RateEmmanuel H Demont, Benjamin I Andrews, Rino A Bit, et al.
Journal of Medicinal Chemistry|August 16, 2011
Discovery of a brain-penetrant S1P₃-sparing direct agonist of the S1P₁ and S1P₅ receptors efficacious at low oral doseEmmanuel H Demont, Sandra Arpino, Rino A Bit, et al.
Journal of Medicinal Chemistry|January 12, 2016
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral DosesEmmanuel H Demont, James M Bailey, Rino A Bit, et al.
Frontiers in Immunology|February 28, 2022
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus MacaquesAndrew D White, Laura Sibley, Charlotte Sarfas, et al.
Science (New York, N.Y.)|September 19, 2009
Ecology. Biodiversity conservation and the Millennium Development GoalsJeffrey D Sachs, Jonathan E M Baillie, William J Sutherland, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
Communications Biology|July 27, 2021
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge modelsTeresa Lambe, Alexandra J Spencer, Kelly M Thomas, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Selective S1P1 Receptor Agonist Efficacious at Low Oral Dose and Devoid of Effects on Heart RateEmmanuel H Demont, Benjamin I Andrews, Rino A Bit, et al.
Journal of Medicinal Chemistry|August 16, 2011
Discovery of a brain-penetrant S1P₃-sparing direct agonist of the S1P₁ and S1P₅ receptors efficacious at low oral doseEmmanuel H Demont, Sandra Arpino, Rino A Bit, et al.
Journal of Medicinal Chemistry|January 12, 2016
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral DosesEmmanuel H Demont, James M Bailey, Rino A Bit, et al.
Frontiers in Immunology|February 28, 2022
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus MacaquesAndrew D White, Laura Sibley, Charlotte Sarfas, et al.
Science (New York, N.Y.)|September 19, 2009
Ecology. Biodiversity conservation and the Millennium Development GoalsJeffrey D Sachs, Jonathan E M Baillie, William J Sutherland, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
Communications Biology|July 27, 2021
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge modelsTeresa Lambe, Alexandra J Spencer, Kelly M Thomas, et al.
Pageof 7